Skip to main content

GE Healthcare Revenue Climbs 8 Percent in Q4 as Profit Surges 16 Percent

NEW YORK (GenomeWeb News) — General Electric today said that fourth-quarter revenue for its Healthcare division rose 8 percent as income swelled 16 percent.
 
GE Healthcare’s receipts for the three months ended Dec. 31, 2006, rose to $4.85 billion from $4.48 billion year over year.
 
GE Healthcare’s earnings for the quarter increased to $1.15 billion from $995 million in the fourth quarter of 2005.
 
GE did not break out its research and development expenses for the Healthcare segment.
 
GE's total revenues for the quarter were $44.6 billion, up from $40.3 billion during the same period last year.
 
Late yesterday afternoon, GE Healthcare said it plans to buy Abbott Technologies’ in vitro and point-of-care divisions for $8.13 billion in cash.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.